BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37116150)

  • 1. Analysis and Validation of the Prognosis ability of the M7GRelated miRNAs in Lung Adenocarcinoma.
    Qiu X; Chen Y; Zhu X; Gong Z; Yu F; Zhang P; Song Y; Li H
    Asian Pac J Cancer Prev; 2023 Apr; 24(4):1275-1287. PubMed ID: 37116150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinoma.
    Duan HP; Yan JH; Nie L; Wang Y; Xie H
    BMC Pulm Med; 2023 Jan; 23(1):14. PubMed ID: 36635678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
    Tan J; Wang W; Song B; Song Y; Meng Z
    Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma.
    Li J; Gu X; Gao C; Zhang J
    Genet Res (Camb); 2022; 2022():5955052. PubMed ID: 36101742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma.
    Zhang Q; Luo Y; Zhang S; Huang Q; Liu G
    Sci Rep; 2024 Feb; 14(1):4257. PubMed ID: 38383747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a 7-miRNA signature for predicting the prognosis of patients with lung adenocarcinoma.
    Liu R; Guo Z; Huang J; Li J; Tan Q; Luo Q
    Exp Biol Med (Maywood); 2022 Apr; 247(8):641-657. PubMed ID: 35068222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Three Differentially Expressed miRNAs as Potential Biomarkers for Lung Adenocarcinoma Prognosis.
    Wang W; Liu B; Duan X; Feng X; Wang T; Wang P; Ding M; Zhang Q; Feng F; Wu Y; Yao W; Wang Q; Yang Y
    Comb Chem High Throughput Screen; 2020; 23(2):148-156. PubMed ID: 31976830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA expression profile and TNM staging system predict survival in patients with lung adenocarcinoma.
    Xin G; Cao X; Zhao W; Lv P; Qiu G; Li Y; Wang B; Fang B; Jia Y
    Math Biosci Eng; 2020 Nov; 17(6):8074-8083. PubMed ID: 33378933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Nomogram Based on Circular RNA-Associated Competing Endogenous RNA Network for Patients with Lung Adenocarcinoma.
    Li Y; Sun R; Li R; Chen Y; Du H
    Oxid Med Cell Longev; 2021; 2021():9978206. PubMed ID: 34497684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray data analysis to identify miRNA biomarkers and construct the lncRNA-miRNA-mRNA network in lung adenocarcinoma.
    Song Y; Kelava L; Zhang L; Kiss I
    Medicine (Baltimore); 2022 Sep; 101(36):e30393. PubMed ID: 36086747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
    Zheng L; Wang J; Jiang H; Dong H
    Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of non-coding RNA-mediated high expression of IQGAP3 in poor prognosis of lung adenocarcinoma.
    Su Z; Wang Y; Cao J; Ma J; Wang G; Ren H; Zhang Y; Sheng K; Zhu X; Wang Y
    J Gene Med; 2024 Jan; 26(1):e3664. PubMed ID: 38282143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel M7G-Related MicroRNAs Risk Signature Predicts the Prognosis and Tumor Microenvironment of Kidney Renal Clear Cell Carcinoma.
    Hong P; Du H; Tong M; Cao Q; Hu D; Ma J; Jin Y; Li Z; Huang W; Tong G
    Front Genet; 2022; 13():922358. PubMed ID: 35812727
    [No Abstract]   [Full Text] [Related]  

  • 15. Biomarker of Pulmonary Inflammatory Response in LUAD: miR-584-5p Targets RAB23 to Suppress Inflammation Induced by LPS in A549 Cells.
    Yang E; Hong Y; Xuan C; Xu J; Ding Q; Zhao S; Ye H; Fan X; Jiang Z; Zhang S; Ding X
    Protein Pept Lett; 2023; 30(10):877-890. PubMed ID: 38093594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes.
    Li F; Niu Y; Zhao W; Yan C; Qi Y
    Sci Rep; 2022 Nov; 12(1):19857. PubMed ID: 36400857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of m7G Methylation-Related miRNA Signature Associated with Survival and Immune Microenvironment Regulation in Uterine Corpus Endometrial Carcinoma.
    Chen R; Sun K; Hou Y; Shen J; Chen J; Dong F; Wang X; Yang L; Zhang L
    Biomed Res Int; 2022; 2022():8776678. PubMed ID: 36467881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the circRNA-miRNA-mRNA Prognostic Regulatory Network in Lung Adenocarcinoma.
    Ma Y; Zou H
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of miRNA Biomarkers in Predicting Overall Survival Outcomes for Lung Adenocarcinoma.
    Li T; Liu H; Dong C; Lyu J
    Biomed Res Int; 2022; 2022():5249576. PubMed ID: 36147635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.
    Wang X; Zhou B; Xia Y; Zuo J; Liu Y; Bi X; Luo X; Zhang C
    BMC Cancer; 2021 Jul; 21(1):801. PubMed ID: 34247575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.